During the past decade, Carilion Clinic Gynecological Oncology conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 30 clinical trials were completed, i.e. on average, 428.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 8 clinical trials were completed. i.e. 266.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Carilion Clinic Gynecological Oncology" #1 sponsor was "Gynecologic Oncology Group" with 19 trials, followed by "National Cancer Institute (NCI)" with 15 trials sponsored, "GOG Foundation" with 5 trials sponsored, "AstraZeneca" with 1 trials sponsored and "CanariaBio Inc." with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Carilion Clinic Gynecological Oncology" #1 collaborator was "National Cancer Institute (NCI)" with 25 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "Gynecologic Oncology Group" with 5 trials as a collaborator, "GOG Foundation" with 1 trials as a collaborator and "Iqvia Pty Ltd" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Carilion Clinic Gynecological Oncology" are "Recurrent Ovarian Carcinoma" (9 trials), "Ovarian Endometrioid Adenocarcinoma" (8 trials), "Ovarian Serous Adenocarcinoma" (8 trials), "Recurrent Fallopian Tube Carcinoma" (8 trials) and "Recurrent Primary Peritoneal Carcinoma" (8 trials). Many other conditions were trialed in "Carilion Clinic Gynecological Oncology" in a lesser frequency.

Most popular intervention types in "Carilion Clinic Gynecological Oncology" are "Drug" (34 trials), "Other" (31 trials), "Biological" (19 trials), "Procedure" (9 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (21 trials), "Paclitaxel" (18 trials), "Quality-of-Life Assessment" (17 trials), "Carboplatin" (13 trials) and "Questionnaire Administration" (8 trials). Other intervention names were less common.

The vast majority of trials in "Carilion Clinic Gynecological Oncology" are 45 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Carilion Clinic Gynecological Oncology". undefined are not yet recruiting, 2 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Carilion Clinic Gynecological Oncology, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Carilion Clinic Gynecological Oncology, 0 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".